Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
10/28/2004 | WO2004038374A3 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
10/28/2004 | US20040215047 Directional-ionizing energy emitting implant |
10/28/2004 | US20040214851 increasing gene expression by contacting with compound comprising imidazoquinoline amine, then contacting with opiod growth factor; pain/scarring reduction |
10/28/2004 | US20040214247 Comprises immunoglobulin which binds to tumor specific epitope and inhibits binding of matrix protein/collagen/gelatin complexes; immunotherapy and antitumor agents |
10/28/2004 | US20040214245 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
10/28/2004 | US20040213833 certain MMP inhibitory peptides improve the targeting of liposomes to cancer cells and enhance the uptake thereof by such cells |
10/28/2004 | US20040213796 Immunotherapy for chronic myelocytic leukemia |
10/28/2004 | US20040213791 Monoclonal antibodies; for diagnosis and treatment of prostate cell proliferative disorders; immunogens; immunotherapy; cell lines |
10/28/2004 | US20040213766 Compositions and methods for treating transplants |
10/28/2004 | US20040213737 Radioactive arsenic-containing compounds and their uses in the treatment of tumors |
10/28/2004 | DE10317461A1 Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt |
10/27/2004 | EP1470129A2 Radiolabeled neuropeptide y y5 receptor antagonists |
10/27/2004 | EP1387701B1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
10/27/2004 | CN1541226A Antibodes specific for CD44V6 |
10/27/2004 | CN1541115A Smulaneous imaging of cardiac perfusion and vitronection receptor targeted imaging agent |
10/27/2004 | CN1541114A Conjugates of macrocyclic metal complexes with biomolucules and utilization thereof for producing agents for use in NMR diagnosis and radiodiagnosis and radiotherapy |
10/27/2004 | CN1539824A Compounds with analygesic effect |
10/27/2004 | CN1539507A Method for preparing radioactive arsenic compound and usage for curing tumour |
10/27/2004 | CN1172721C Tumour positive electron developer S-(18 fluro-n-alkyl)-L-methionine and its preparation method |
10/26/2004 | US6808930 Labelling reagent; can be used in diagnosis and therapy of cancer/tumors; detection of penetration of nucleus susceptible to alpha-lactalbumin (mal) |
10/26/2004 | US6808875 Methods for screening cellular proliferation using isotope labels |
10/26/2004 | US6808698 Using transition metal radionuclide complex to bind glycoprotein; two-dimensional images are assembled into three-dimensional matrix data to determine a maximum value along each line and then assigned a pixel |
10/26/2004 | CA2261827C Use of amines to produce drugs for preventing tumour cell proliferation |
10/26/2004 | CA2177616C Preparation and use of immunoconjugates |
10/21/2004 | WO2004089984A1 Antigen recognizing antibody |
10/21/2004 | WO2004089517A1 Method of obtaining galliun-68 and use thereof and device for carrying out saif method |
10/21/2004 | WO2004089426A2 Radiolabelled cytokines for scintigraphic imaging of chronic lymphocyte-mediated inflammation |
10/21/2004 | WO2004089425A1 Microwave method for preparing radiolabelled gallium complexes |
10/21/2004 | WO2004071505A3 Radiolabelled d-amino acids for use in diagnosis with spect and pet and systemic radionuclide therapy |
10/21/2004 | WO2003026490A3 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules |
10/21/2004 | US20040208919 Vaccination against prion diseases |
10/21/2004 | US20040208892 Using labeled sodium bicarbonate as carbon source for diagnostic mesurement of bulk drug synthesis in algal biomass; bioreators and drug biosynthesis |
10/21/2004 | US20040208828 Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecanedioic acid and derivatives thereof, process for their production and use for the production of pharmaceutical agents |
10/21/2004 | US20040208827 Diagnostic imaging contrast agents with extended blood retention |
10/21/2004 | US20040208822 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
10/21/2004 | US20040208821 Administering a soft tissue targeting complex of thorium-227 and a complexing agent, in vivo nuclear decay to radium-223; drug targets for treating cancer |
10/21/2004 | CA2501222A1 Antibody recognizing antigen |
10/20/2004 | EP1467757A2 Use of antibodies against the muc18 antigen |
10/20/2004 | EP1467756A2 Methods for using anti-muc18 antibodies |
10/20/2004 | EP1390549A4 Metal-zirconia composite coating |
10/20/2004 | EP0732939B1 Preparation and use of immunoconjugates comprising a VL-chain glycosylated at the Asn in position 18 |
10/20/2004 | EP0727959B1 Diagnostic uses of hydrazinoadenosines |
10/20/2004 | CN1537648A Saccule catheter type tumour close internal radiation therapy device |
10/20/2004 | CN1171997C Modified TLE-2-receptor ligands |
10/20/2004 | CN1171641C Iodine [125I] radioactive sealed source preparation process |
10/19/2004 | US6806281 Treatment of cocaine abuse, parkinson's disease |
10/19/2004 | CA1341459C Modified fibrinolytic enzymes |
10/14/2004 | WO2004088279A2 Allosteric probes and methods |
10/14/2004 | WO2004087656A1 Conjugates of 2,4-ethano-bridged and 2,4-propano-bridged 3,6,9-triaza-nonanoic acid, 3n,6n,9,9n-tetraethanoic acid, and corresponding phosphoric acid methylene derivatives and the substitution products thereof with biomolecules, methods for the production thereof, and the use of the same for produ |
10/14/2004 | WO2004040972A3 Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same |
10/14/2004 | WO2004033667A3 Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope |
10/14/2004 | US20040204387 administering to subject a pharmaceutically effective amount of inositol stereoisomers, enantiomers or derivatives thereof; for treating or preventing condition of central or peripheral nervous system or systemic organ associated with a disorder in protein folding or aggregation, or amyloid formation |
10/14/2004 | US20040204357 Modulator of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics |
10/14/2004 | US20040204344 bifunctional molecules containing at least one metal-chelating group associated with at least one amyloid-binding group e.g a benzothiazole derivative; for treating pathophysiological condition selected from Alzheimer's disease, Down's syndrome, Lewy body dementia, Guam Parkinson-Dementia, head trauma |
10/14/2004 | US20040203065 Novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
10/14/2004 | US20040203014 Neurotransmisson-associated proteins |
10/14/2004 | US20040202613 Chelate compounds |
10/14/2004 | US20040202612 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
10/14/2004 | US20040202610 Method and apparatus including use of metalloporphyrins for subsequent optimization of radiosurgery and radiotherapy |
10/14/2004 | US20040202609 administering a cytotoxic compound of porphyrin complexed with a radioactive metal to a mammal; treating arteriosclerotic lesions; radioactive metal is cytotoxic to cells in and surrounding the plaque |
10/13/2004 | EP1466172A1 Breath test |
10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
10/13/2004 | EP1465938A1 Dendritic poly (amino acid) carriers and methods of use |
10/13/2004 | EP1465670A2 Labeling targeting agents with gallium-68 and gallium-67 |
10/13/2004 | EP1465666A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
10/13/2004 | EP1465661A1 Cancer treatment |
10/13/2004 | EP1053027B1 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi |
10/13/2004 | EP0637933B1 Method for treating organs and tissues |
10/13/2004 | CN1170933C Motilin homologs |
10/13/2004 | CN1170593C Immunogenic compsns to CK-b/gastrin-receptor and methods for treatment of tumors |
10/12/2004 | US6803364 Il-5 inhibiting 6-azauracil derivatives |
10/07/2004 | WO2004085452A1 Compound having affinity with calcified tissue |
10/07/2004 | WO2004084953A1 Modulators of the megalin-mediated uptake of radiotherapeutics and/or radiodiagnostics into kidney cells and their use in therapy and diagnostics |
10/07/2004 | WO2004084823A2 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
10/07/2004 | WO2004011426A3 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
10/07/2004 | WO2003059942A3 Peptides and peptidomimetics having anti-proliferative activity and their use |
10/07/2004 | US20040198660 the TF antagonist is a factor VII polypeptide having reduced ability to catalyze factor X to factor Xa by being catalytically inactivated by a chloromethylketone inhibitor; anticoagulants, antiinflammatory agents; respiratory system disorders |
10/07/2004 | US20040198638 Administering docetaxel or paclitaxel derivative conjugated to polyglutamic acid, polyaspartic acid, or polylysine as antitumor or anticarcinogenic agent; radiation; autoimmune disorders, rheumatoid arthritis; coatings of stents for prevention of restenosis |
10/07/2004 | US20040197844 Marker for inflammatory conditions |
10/07/2004 | US20040197392 comprising 1-acyl-2-acyl-glycero-3-phosphoethanolamine and 1-acyl-2-acylsuccinylglycerol or 1-acyl-3-acylsuccinylglycerol; identification of a tumour, inflammation or cardiac infarct tissue in a human or non-human animal; Magnetic Resonance imaging |
10/07/2004 | US20040197337 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
10/07/2004 | US20040197328 Screening; separation using cancer cytotoxicity; diagnosis; anticancer, antitumor agents; administering monoclonal antibodies |
10/07/2004 | US20040197302 Positioning in mammalian body ; solidification when exposured to trigger |
10/07/2004 | US20040197269 Ultrasound contrast media, contrast agents containing the media and method |
10/07/2004 | US20040197268 Alzheimer's disease therapy |
10/07/2004 | US20040197264 Microspheres comprising therapeutic and diagnostic radioactive isotopes |
10/07/2004 | CA2520147A1 Compound having affinity with calcified tissue |
10/07/2004 | CA2519528A1 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof |
10/06/2004 | EP1463721A1 Compounds for imaging alzheimer's disease |
10/06/2004 | EP1463533A2 Radioactive ion |
10/06/2004 | CN1535268A Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
10/06/2004 | CN1535163A Delivery system for nucleic acids |
10/06/2004 | CN1169581C Pd-103 seed medicine and its prepn |
10/06/2004 | CN1169580C 166 Ho-DTPA, its preparing method and application as liquid radiation source |
10/06/2004 | CN1169579C Medicine C60-AEDP using C60 as carrier for target therapy of osteopath and its usage |
10/05/2004 | US6800273 Anticancer agents; angiogenosis inhibitors |
09/30/2004 | WO2004083902A2 Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring |
09/30/2004 | WO2004082722A2 Radiolabeled conjugates based on substance p and the uses thereof |
09/30/2004 | WO2004082627A2 ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 |
09/30/2004 | WO2004082626A2 Aromatase inhibitor diagnosis and therapy |